EP3300733A1 - SUBSTANCE SELECTED AMONG IRINOTECAN, AN IRINOTECAN ACTIVE METABOLITE, 5-FLUORO-URACILE, A PHARMACEUTICAL SALT THEREOF AND A MIXTURE THEREOF, FOR USE IN THE TREATMENT OF FIBROSIS